Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
THE CHEMOKINE FRACTALKINE (CX3...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
THE CHEMOKINE FRACTALKINE (CX3CL1) HAS ANTI-APOPTOTIC AND PROLIFERATIVE EFFECTS ON PRIMARY HUMAN SMOOTH MUSCLE CELLS VIA EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALLING
Bibliographic Details
Main Authors:
White, G
,
Greaves, D
Format:
Conference item
Published:
2009
Holdings
Description
Similar Items
Staff View
Similar Items
Fractalkine has anti-apoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signalling.
by: White, G, et al.
Published: (2010)
Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1).
by: Lucas, A, et al.
Published: (2003)
The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo.
by: Lucas, A, et al.
Published: (2001)
The CX3C chemokine fractalkine acts via an extracellular regulated kinase-dependent mechanism to induce human coronary artery smooth muscle cell proliferation
by: White, G, et al.
Published: (2007)
Fractalkine: one chemokine, many functions.
by: White, G, et al.
Published: (2009)